Biodesix, Inc. Common Stock
$29.20
$0.39 (+1.35%)
$28.39Day Range$29.96
Key Statistics
Market Cap
$308.09M
Shares Outstanding
10.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 28, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$28.52
Day High
$29.96
Day Low
$28.39
Volume
100.9K
VWAP
$29.26
Prev Close
$28.81
Transactions
--
Acc. Volume
--
About Biodesix, Inc. Common Stock
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
SERVICES-MEDICAL LABORATORIESSIC 8071334 employees919 WEST DILLON ROAD, LOUISVILLE, CO, 80027303-417-0500IPO Oct 28, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001439725
- Composite FIGI
- BBG001J2LMV6
- Share Class FIGI
- BBG001V0G914
- Ticker Root
- BDSX
- SIC Code
- 8071
About Biodesix, Inc. Common Stock (BDSX) Stock
Biodesix, Inc. Common Stock (BDSX) closed the 2026-09-18 session at $29.20, up 1.35% versus the previous close (+0.39). The stock opened at $28.52 and traded between $28.39 and $29.96 during that session. Session trading volume was 101K shares. The volume-weighted average price (VWAP) is $29.26.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
Biodesix, Inc. Common Stock has a market capitalization of $308.1 million. The company operates in the SERVICES-MEDICAL LABORATORIES industry classification. BDSX is listed on the XNAS exchange. The company employs approximately 334 people. Biodesix, Inc. Common Stock is headquartered in LOUISVILLE, CO. The recorded listing date is 2020-10-28.
On this page you can find market BDSX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-MEDICAL LABORATORIES sector.